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Background: Sometimes even in adequate graft to recipient weight ratio (GRWR) settings and after ruling
out all other causes, recipients still show features of the small for size syndrome. The purpose of this
study was to evaluate all causative factors responsible for early graft dysfunction fulﬁlling the deﬁnition
of the small for size syndrome, regardless of the GRWR status, and with particular emphasis on portal
ﬂow (ml/min/100 g). We also tried to establish whether a high portal ﬂow on intraoperative Doppler
study immediately after reperfusion can predict graft dysfunction.
Material and methods: Early graft dysfunction was deﬁned according to the deﬁnitions given for the
small for size syndrome by the Kyushu University Group. Patients undergone living donor liver trans-
plantations between January 2010 and December 2012 were analyzed. We routinely do Doppler ultra-
sound (USG) immediately after reperfusion and daily for 5 days. The portal vein ﬂow after routine
Doppler examination immediately after reperfusion was noted as the portal vein ﬂow at day 0.
Results: 19 of 134 patients showed features of early graft dysfunction as deﬁned. On univariate analysis,
hepatitis C virus (HCV) and portal vein ﬂow immediately after reperfusion were signiﬁcant predictors of
postoperative graft dysfunction. (p ¼ 0.008 and p < 0.0001). On multivariate logistic regression, only
portal vein ﬂow after reperfusion (p ¼ 0.002) remained as the signiﬁcant predictor of postoperative graft
dysfunction. A portal ﬂow of greater than 190 (ml/min/100 g) was signiﬁcant in predicting graft
dysfunction (p < 0.0001) with an AUROC of 0.709. GRWR was not a signiﬁcant predictor.
Conclusion: A portal vein ﬂow immediately after reperfusion >190/ml/min/100 g. reliably predicted
whether a graft would behave as small for size or not, regardless of the GRWR status. Portal vein ﬂow
was the most signiﬁcant predictor of graft dysfunction.
 2013 Surgical Associates Ltd. Published by Elsevier Ltd. All rights reserved.1. Introduction
It is well known that the small for size syndrome occurs when the
graft to recipient weight ratio (GRWR) is <0.8. However, sometimes
even in adequate GRWR settings, and after ruling out all possible
causes, liver transplant recipients still show features of the small for
size syndrome.1 Studies have shownan important pathophysiology in
the development of the small for size syndrome is high portal ﬂow.2,32. Aims and objectives
The purpose of this study was to evaluate all causative factors
responsible for early graft dysfunctionwhich fulﬁlled the deﬁnition9@gmail.com (B.B. Vasavada).
ciates Ltd. Published by Elsevier Ltof the small for size syndrome regardless of the GRWR status, with
particular emphasis on portal ﬂow (ml/min/100 g). We also tried to
establish whether a high portal ﬂow on Doppler study immediately
after reperfusion can predict graft dysfunction.3. Deﬁnitions
Early graft dysfunction was deﬁned according to the deﬁnitions
used for the small for size syndrome by the Kyushu University
Group.5
The Kyushu University Group deﬁned the small for size syn-
drome as “a total bilirubin concentration >86.2 mmol/l (5 mg/dl) on
postoperative day 14 in the absence of any other deﬁnitive causes of
cholestasis, such as technical problems or immunological and in-
fectious conditions, with presence of intractable ascites (deﬁned as
a daily production of ascites of>1000ml on postoperative day 14 or
>500 ml on postoperative day 28)”. Their exclusion criteria wered. All rights reserved.
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congestion, bile leak), immunological (e.g. rejection), or infectious
(e.g. cholangitis, sepsis)”.
We deﬁned early graft dysfunction using the postoperative
criteria of the above deﬁnitions, regardless of GRWR status, as we
wanted to study the causes of early graft dysfunction in normal size
grafts.
4. Material and methods
4.1. Patient selection
Patients who underwent living donor liver transplantation be-
tween January 2010 and December 2012 were analyzed.
4.2. Exclusion criteria
As deﬁned in the Kyushu University deﬁnitions patients who
had arterial or portal occlusion, congestion, bile leak, biopsy proven
rejection or infection complication like cholangitis and sepsis
deﬁned by any culture positivity were excluded.
134 patients were included in this study. Patients who fulﬁlled
the above deﬁnitions were included into the “graft dysfunction”
group and all other patients were included into the “non-graft
dysfunction group”. The portal ﬂow was measured by intra-
operative Doppler immediately after reperfusion (portal ﬂow day
0). We carried out ultrasound (USG) Doppler examinations imme-
diately after reperfusion, and daily for the ﬁrst 5 postoperative days.
We used a standard hepatic vascular protocol with an Acuson 128
scanner (Acuson, Mountain View, CA, USA) followed by a 7.0 or
4.0 MHz scanner. The ﬂow velocity and cross-sectional area of the
portal vein (PV) were measured with a Doppler mode. The portal
ﬂow was calculated by the ﬂow velocity and the portal vein
diameter just beyond the portal vein anastomosis. A mean of three
consecutive readings was taken for analysis.
Other characteristics affecting graft function like age, sex, pre-
operative MELD score, preoperative Child-Turcotte-Pugh (CTP)
score, etiology of disease, right or left liver were noted. Decision
regarding a right or left liver graft and whether to include the
middle hepatic vein or not were decided according to the In-
stitutions Protocol as published before.6
4.3. Statistics
All statistics were done using the SPSS version 21 software
(IBM). Univariate analyses of clinical risk factors associated with
early graft dysfunction were conducted using chi-squared tests for
categorical variables and t tests for continuous variables after
assessing for normality. The risk factor variables with a P < 0.20 on
univariate analysis were included in an explanatory analysis using
the multivariable logistic regression model to adjust for potential
confounding. P values of <0.05 were considered as statistically
signiﬁcant. To determine the predictive power of the intraoperative
portal ﬂow, receiver-operating characteristic (ROC) curves were
developed. The area under the receiver operating characteristic
curve (AUROC) was considered a useful predictor at a value greater
than 0.7.
4.4. Results
19 of 134 patients showed features of early graft dysfunction as
by the deﬁnitions used. The patients’ characteristics and their P
values on univariate analysis are shown in Table 1.All grafts had
<10% steastosis on computed tomography (CT) estimation.4.5. Univariate analysis
As shown in Table 1, only hepatitis C virus (HCV) and portal vein
ﬂow immediately after reperfusion were signiﬁcant predictors of
graft dysfunction (P < 0.05). However the preoperative CTP score
and MELD score showed P values <0.2 and they were included in
the multivariate logistic regression analysis to eliminate any con-
founding effect. The GRWR was not signiﬁcantly associated with
graft dysfunction. Only 3 patients in the graft dysfunction group
had a GRWR less than 0.8 while 16 patients in the non-graft
dysfunction group had a GRWR less than 0.8. This showed that
the features of graft dysfunction were not entirely dependent upon
the GRWR status.
4.6. Multivariate logistic regression analysis
Portal vein ﬂow immediately after reperfusion, HCV as etiology,
preoperative CTP and MELD score were tested using the multivar-
iate logistic regression analysis. Only portal vein ﬂow after reper-
fusion was a signiﬁcant predictor of postoperative graft
dysfunction. (p ¼ 0.002) (95% conﬁdence interval- 1.009e1.041)
with hazard ratio (1.025).
4.7. The predicting cut-off value of portal ﬂow for postoperative
graft dysfunction in normal GRWR grafts
On ROC curve, portal ﬂow ml/min/100 g immediately after
reperfusion showed an AUROC of 0.792 [Fig. 1]. A portal ﬂow
greater than 190 ml/min/100 mg had the highest sensitivity and
speciﬁcity (Fig. 2).
The Fisher t test was applied to test the statistical signiﬁcance of
portal ﬂow greater than 190 ml/min/100 g. in predicting post-
operative graft dysfunction. 10 of 19 patients in the graft dysfunc-
tion group showed a portal vein ﬂow of greater than 190 ml/min
whereas only 17 of 115 in the non-graft dysfunction group showed
a portal vein ﬂowof greater than 190ml/min (p value<0.0001 odds
ratio: 7.56, 95% conﬁdence interval 2.48e23.03).
4.8. ROC curve estimation for portal ﬂow 190 ml/min/100 g
The ROC curve for a portal ﬂow 190 ml/min/100 g. showed a p
value of 0.007 with 95% CI of 0.556 and 0.861.
4.9. Discussion
Post-hepatectomy liver failure is deﬁned as persistence of
hyperbilirubinemia, coagulopathy, encephalopathy, prolonged as-
cites in recipients after living donor liver transplantation, particu-
larly with a GRWR <0.8. This is known as the small for size
syndrome.7 Kiuchi et al.8 showed high mortality and morbidity
rates in patients with a graft weight to recipient weight ratio
(GRWR)<0.8. However, Hill et al.20 showed that GRWRwas not the
only factor responsible for the small for size syndrome. There are
recent studies suggesting that portal ﬂow is more important that
size alone in the pathophysiology of the small for size syndrome.
Troisi et al.9 showed that portal ﬂow inﬂow modulation to slow
down the portal ﬂowwhen it was greater than 250ml/min/100 g of
graft signiﬁcantly improved patient and graft survival as well as
reversed the histological changes of hepatic injury in small for size
grafts. Lautt et al.11 suggested the “adenosine washout hypothesis”
was responsible for this. A constant release of adenosine, a vaso-
dilator substance, among the hepatic arterioles and portal venules
maintains a balanced inﬂow. Increased portal ﬂow decreases local
adenosine concentrations, thus resulting in hepatic artery branch
constriction and reduction in arterial ﬂow, which is responsible for
Table 1
Patient characteristics and univariate analysis.
Patients
characteristics
Graft
dysfunction
Nongraft
dysfunction
P value
Age 46.32(mean) 
18.391 (SD)
47.51(mean) 
16.972
P ¼ 0.675
Sex 14-m, 5-f 89-m-26-f P ¼ 0.724
Etiology HBV 1(n) 18(n) P ¼ 0.286
HCV 6(n) 13(n) P ¼ 0.020
HBV with HCC 3(n) 40(n) P ¼ 0.166
HCV with HCC 2(n) 17(n) P ¼ 0.738
HCC 2(n) 7(n) P ¼ 0.391
Alcoholic liver
disease
2(n) 8(n) P ¼ 0.490
HBV with HCV 0(n) 3(n) P ¼ 0.500
HBV with HCV
with HCC
0(n) 2(n) P ¼ 0.583
Others 1(n) 4(n) P ¼ 0.504
Graft (lobe) Right (n ¼ 13)
left(n ¼ 6)
Right (89)
left (27)
P ¼ 0.564
(signiﬁcance
of left lobe in
predicting graft
dysfunction)
GRWR 0.8 (n ¼ 16),
<0.8 (n ¼ 3)
0.8 (n ¼ 99),
<0.8 (n ¼ 16)
P ¼ 0.714
Portal ﬂow(ml/min/
100 g of graft
weight)
193.136(mean) 
53.653 (SD)
138.85(mean) 
55.32 (SD)
P < 0.0001
MELD 16.625(mean) 
7.965(SD)
13.640(mean) 
6.716
P ¼ 0.119
CTP 9.333(mean) 
2.424(SD)
8.2302(mean) 
2.424(SD)
P ¼ 0.151
Fig. 2. ROC curve for portal ﬂow greater than 190 ml/min/100 mg.
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formulated a hypothesis that “the development of the “small-for-
size” syndrome is not exclusively determined by the ratio of the
mass of the liver remnant (or graft) to the body weight, but it isFig. 1. ROC curve for portal ﬂow ml/min/100 g.instead strictly determined by the haemodynamic parameters of
the hepatic circulation”.
We used the portal ﬂow instead of the portal pressure in our
study because of the ﬁndings of Troisi et al.,9 and to test the hy-
pothesis by Asencio.7 Also Chan et al. from Hong Kong22 showed
that the graft portal inﬂow, when expressed as the volume per
100 g of graft weight per minute, had a linear correlation with the
recipient portal pressure before hepatectomy of the native liver,
and it was weaker in the an hepatic phase but not after graft im-
plantation They showed that the post-reperfusion portal ﬂow was
not correlated with the portal pressure. Troisi et al.9 also suggested
that following reperfusion of a partial graft, the haemodynamic
changes were much more pronounced than those occurring in
cadaveric liver transplants, with an inverse correlation to the
GRWR. Overall the mean portal vein ﬂow (PVF) values were
increased at least twice the donor values and the portal contribu-
tion may raise the total graft inﬂow. They also suggested that
“hyper-perfusion of small grafts is thought to be one of the main
causes of post-transplant graft dysfunction (SFSS), and poor graft
outcome has been reported in patients with PVF values of more
than 260 mL/min/100 g. graft and small grafts”.
Chan et al. also suggested portal hyperperfusion is an indication
of possible portal hypertension. Portal manometry can be carried
out with cannulation of the inferior mesenteric vein or by direct
puncture of the portal vein. The latter, however, does not allow
continuous monitoring, and portal pressure can vary with central
venous pressure, which in turn can vary with the positions of the
patient and the catheter tip.23 Barriga et al.24 found no correlation
between the post-reperfusion portal pressure and portal ﬂow. They
suggested that the need for portal ﬂow modulation does not
require elevation of both. They also described that the portal ﬂow
modulation technique has a direct effect on the portal ﬂow.8
Most of the studies, to the best of our knowledge, have been
carried out in small for size settings. However sometimes even
grafts with adequate size and GRWR >0.8 also show signs of post-
hepatectomy liver failure.1 Very few researchers have addressed
this issue. The purpose of this study was to study the factors
responsible for post-hepatectomy graft dysfunction and to study
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dysfunction in normal for size settings.
We deﬁned the small for size syndrome using the Kyushu Uni-
versity Deﬁnitions for the small for size syndrome,4,5 however we
omitted the GRWR as the criteria to study graft dysfunction. Only 3
patients out of 19 patient who showed symptoms of graft
dysfunction has a GRWR less than 0.8 and the other 16 patients
who has a GRWR less than 0.8 did not show any signs of graft
dysfunction, suggesting that GRWR is not the prime factor
responsible for graft dysfunction.
On univariate analysis hepatitis c virus and portal ﬂow were
signiﬁcant predictors of graft dysfunction. However, preoperative
MELD and CTP scores showed p values<0.2. In order to rule out the
effect of preoperative disease status of the recipients on the post-
operative outcomes we included them into the multivariate anal-
ysis. After multivariate analysis only portal ﬂow was signiﬁcantly
associated with postoperative graft dysfunction, suggesting that
portal ﬂow by Doppler ultrasound immediately after reperfusion is
the most important predictor of postoperative graft function after
excluding patients having arterial or portal occlusion, congestion,
bile leak, biopsy proven rejection or infection complication like
cholangitis and sepsis as deﬁned by any culture positivity.
A portal ﬂow greater than 190 ml/min/100 mg showed the
highest sensitivity and speciﬁcity on ROC curve. Troisi et al.9,12 and
Kato et al.13 showed worse outcome with a portal ﬂow greater than
250 ml/min/100 g. However their study group included grafts with
GRWR <0.8. On the other hand, our study included patients with
adequate graft weight. Thus, the mean graft weight was much
higher in our study and that explains the low cut-off value of portal
ﬂow in our study.
This study has several limitations. It is a retrospective study so
the drawbacks associatedwith any retrospective studywill be there
in this study also. Also, the sample size of the graft dysfunction
group was very low, because of our strict exclusion criteria as we
wanted to eliminate all other differential diagnosis.5. Conclusion
A high portal ﬂow, but not the GRWR, is the main factor asso-
ciated with graft dysfunction. Even in patients with an adequate
GRWR, a high portal ﬂowwas associatedwith poor graft function. A
portal vein ﬂow immediately after reperfusion >190/ml/min/
100 g more reliably predicted graft dysfunction using the small for
size syndrome deﬁnitions even in normal GRWR settings.Ethical approval
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